Literature DB >> 3875059

Regional blood flow in hemiparkinsonism.

J S Perlmutter, M E Raichle.   

Abstract

Positron emission tomography was used to measure global and local blood flow in 11 patients with hemiparkinsonism (before and after an acute oral dose of L-dopa) and in 26 normal subjects. Global hemispheric blood flow was not significantly different between the patients [45 +/- 11 ml/(min X 100 g)] and the controls [49 +/- 8 ml/(min X 100 g)]. After L-dopa, the patients' mean global hemispheric flow did not change. Measurements of local blood flow from specific, anatomically defined cortical and basal ganglia regions were performed using a newly developed stereotactic localization technique. Before L-dopa, mesocortical blood flow contralateral to the patients' symptoms was significantly less than controls (p less than 0.003), suggesting a specific abnormality in the cortical dopaminergic projection from the ventral tegmental area. In addition, right and left pallidal blood flow were significantly less tightly coupled in patients than controls (p = 0.0312). After L-dopa, the mesocortical blood flow remained below normal, whereas pallidal blood flow was no longer significantly different from controls (p greater than 0.05).

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3875059     DOI: 10.1212/wnl.35.8.1127

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  17 in total

Review 1.  PET and movement disorders.

Authors:  D J Brooks; R S Frackowiak
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-06       Impact factor: 10.154

2.  Subcutaneous apomorphine increases regional cerebral blood flow in parkinsonian patients via peripheral mechanisms.

Authors:  U Sabatini; O Rascol; P Celsis; G Houin; A Rascol; J P Marc-Vergnes; J L Montastruc
Journal:  Br J Clin Pharmacol       Date:  1991-08       Impact factor: 4.335

3.  Hemiparkinsonism following haemorrhage in the contralateral substantia nigra.

Authors:  K Abe; T Yanagihara
Journal:  Neuroradiology       Date:  1996-05       Impact factor: 2.804

4.  Cognitive and SPECT characteristics predict progression of Parkinson's disease in newly diagnosed patients.

Authors:  Kathy Dujardin; Luc Defebvre; Alain Duhamel; Pascal Lecouffe; Pascal Rogelet; Marc Steinling; Alain Destée
Journal:  J Neurol       Date:  2004-11       Impact factor: 4.849

5.  Thalamocortical dysrhythmia: A neurological and neuropsychiatric syndrome characterized by magnetoencephalography.

Authors:  R R Llinás; U Ribary; D Jeanmonod; E Kronberg; P P Mitra
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

6.  Prefrontal cortical blood flow and cognitive function in Huntington's disease.

Authors:  D R Weinberger; K F Berman; M Iadarola; N Driesen; R F Zec
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-01       Impact factor: 10.154

7.  Emergent Functional Network Effects in Parkinson Disease.

Authors:  Caterina Gratton; Jonathan M Koller; William Shannon; Deanna J Greene; Baijayanta Maiti; Abraham Z Snyder; Steven E Petersen; Joel S Perlmutter; Meghan C Campbell
Journal:  Cereb Cortex       Date:  2019-06-01       Impact factor: 5.357

8.  Occipital hypoperfusion in Parkinson's disease without dementia: correlation to impaired cortical visual processing.

Authors:  Y Abe; T Kachi; T Kato; Y Arahata; T Yamada; Y Washimi; K Iwai; K Ito; N Yanagisawa; G Sobue
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-04       Impact factor: 10.154

9.  Technetium-99m hexamethylpropylene amine oxime single photon emission tomography of the brain in early Parkinson's disease: correlation with dementia and lateralization.

Authors:  S J Wang; R S Liu; H C Liu; K N Lin; D E Shan; K K Liao; J L Fuh; L S Lee
Journal:  Eur J Nucl Med       Date:  1993-04

10.  Cognition and cerebral blood flow in lateralised parkinsonism: lack of functional lateral asymmetries.

Authors:  A Agniel; P Celsis; G Viallard; J L Montastruc; O Rascol; J F Demonet; J P Marc-Vergnes; A Rascol
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-09       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.